D. M. Spencer

Developments in suicide genes for preclinical and clinical applications.

D. M. Spencer, 2000, Current opinion in molecular therapeutics.

Antiangiogenic gene therapy: disruption of neovascular networks mediated by inducible caspase-9 delivered with a transcriptionally targeted adenoviral vector

W. Song, G. Núñez, Q. Sun, 2005, Gene Therapy.

Creating conditional mutations in mammals.

D. M. Spencer, 1996, Trends in genetics : TIG.

Lipid raft‐targeted Akt promotes axonal branching and growth cone expansion via mTOR and Rac1, respectively

M. Grider, H. Shine, D. Park, 2009, Journal of neuroscience research.

Identification of Macromolecular Targets for Formaldehyde-Activated Adriamycin

Don R. Phillips, Abraham Nudelman, Ada Rephaeli, 2002 .